Plasma concentrations of tumour necrosis factor-alpha, tumour necrosis factor-related apoptosis-inducing ligand, and FasLigand/CD95L in patients with Chagas cardiomyopathy correlate with left ventricular dysfunction.
about
Adipose Tissue-Derived Mesenchymal Stromal Cells Protect Mice Infected with Trypanosoma cruzi from Cardiac Damage through Modulation of Anti-parasite ImmunityEtanercept induces low QRS voltage and autonomic dysfunction in mice with experimental Chagas disease.β-Adrenergic receptor-mediated transactivation of epidermal growth factor receptor decreases cardiomyocyte apoptosis through differential subcellular activation of ERK1/2 and Akt.Evaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review.Immunoregulatory mechanisms in Chagas disease: modulation of apoptosis in T-cell mediated immune responses.Src Family Kinases Modulate the Loss of Endothelial Barrier Function in Response to TNF-α: Crosstalk with p38 Signaling.Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease.Trypanosoma cruzi P21: a potential novel target for chagasic cardiomyopathy therapy.Synergic and antagonistic relationship between MMP-2 and MMP-9 with fibrosis and inflammation in Chagas' cardiomyopathy.Interleukin-10 and tumour necrosis factor-alpha serum levels in chronic Chagas disease patients.Protein deficiency alters CX3CL1 and endothelin-1 in experimental Trypanosoma cruzi-induced cardiomyopathy.Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease.Distinct Trypanosoma cruzi isolates induce activation and apoptosis of human neutrophils.Correlation of transforming growth factor-β1 and tumour necrosis factor levels with left ventricular function in Chagas disease.
P2860
Q27304355-D901617E-B494-498A-9624-3554658B4F68Q33655042-7F72452B-09EB-4336-9265-9CFBB52B490BQ33680497-163D1C0A-74F7-4026-BD3F-729384735DD8Q34992879-FF9EAC25-372A-4907-8D4E-715BCC4BF6F5Q36006382-7D0E21AA-9064-4B99-B756-7E8D659C9791Q36125360-B8E9E8BA-77E0-41B5-BE2D-8B6C855FD92FQ36904784-3D9FEA46-1B4F-44A7-A0E1-1CD647277C0EQ38819127-E3713B8E-7609-4282-9AE9-F55CF17303FFQ39329438-E9F937A1-1742-489F-995F-72CE4855ECEEQ41457003-55BF5A0D-0197-4D73-AC6B-2FAD04CECE19Q44986627-292A60F4-FE0A-46C5-A729-23D75445C96AQ46063891-149DBFB7-9929-4730-A8F7-623CCCB12CDAQ47153536-656975B2-51A4-4059-BB44-786082EC8F34Q55220404-70FE04D0-8598-4208-A9CF-9B0D4E92E6DF
P2860
Plasma concentrations of tumour necrosis factor-alpha, tumour necrosis factor-related apoptosis-inducing ligand, and FasLigand/CD95L in patients with Chagas cardiomyopathy correlate with left ventricular dysfunction.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Plasma concentrations of tumou ...... left ventricular dysfunction.
@en
Plasma concentrations of tumou ...... left ventricular dysfunction.
@nl
type
label
Plasma concentrations of tumou ...... left ventricular dysfunction.
@en
Plasma concentrations of tumou ...... left ventricular dysfunction.
@nl
prefLabel
Plasma concentrations of tumou ...... left ventricular dysfunction.
@en
Plasma concentrations of tumou ...... left ventricular dysfunction.
@nl
P2093
P2860
P356
P1476
Plasma concentrations of tumou ...... left ventricular dysfunction.
@en
P2093
André Talvani
Jamille Fernandes Lula
Maria Terezinha Bahia
Maria do Carmo Pereira Nunes
Mauro Martins Teixeira
P2860
P304
P356
10.1093/EURJHF/HFP105
P577
2009-08-04T00:00:00Z